Description

Tirzepatide

•  (Type 2 Diabetes): Approved for adults and children aged 10 and older to improve blood sugar control.
•  (Weight Management):Approved for chronic weight management in adults with obesity (BMI≥30) or overweight (BMI≥27) with at least one weight-related condition.
• Obstructive Sleep Apnea (OSA): Approved (as Zepbound) to treat moderate-to-severe OSA in adults with obesity.
• For Research Use Only

We have more information about this item and the reconstituted pen visit Tirzepatide pen to see more details

• For more studies you can check out Nova Pharma Labs